Integra LifeSciences Corporation
Clinical trials sponsored by Integra LifeSciences Corporation, explained in plain language.
A medical technology company focused on surgical instruments and neurosurgical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New dressings aim to close stubborn wounds faster Results expected Dec 2026 (estimated)
-
New dressing shows promise for Hard-to-Heal wounds
Disease control CompletedThis study tested a special wound dressing called MicroMatrix Flex on 25 adults with deep or tunneled wounds, such as pressure injuries, diabetic ulcers, or infected wounds. The goal was to see how safely and quickly the dressing helped close these wounds over 12 weeks. Researche…
Sponsor: Integra LifeSciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Brain drain device registry completed – no major surprises
Knowledge-focused CompletedThis completed registry followed 120 patients who received an Integra external ventricular drainage (EVD) system to drain excess fluid from the brain. The goal was to check how well the device performed and how safe it was in real-world use. Researchers measured whether the drain…
Sponsor: Integra LifeSciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC